Online inquiry

IVTScrip™ mRNA-Human APOBEC3A, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A))   (CAT#: GTTS-WK23719MR)

This product GTTS-WK23719MR is a type of mRNA having 30 nt poly(A) tail and modified with Cap 0 & N1-Methylpseudo-UTP. It ecodes the APOBEC3A protein. This product can be used in Secretory progenitor cell-related researches.
Specifications
Product type mRNA
Modified bases N1-Methylpseudo-UTP
5' Cap Cap 0
Species Human
RefSeq NM_001270406.2
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 200315
UniProt ID P31941
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human APOBEC3A, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A)) (GTTS-WK23719MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK7722MR IVTScrip™ mRNA-Human ADCY7, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ADCY7
GTTS-WK28757MR IVTScrip™ mRNA-Human ATG2A, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ATG2A
GTTS-WK22223MR IVTScrip™ mRNA-Human APOBEC3G, (Cap 0, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA APOBEC3G
GTTS-WK13629MR IVTScrip™ mRNA-Human ACLY, (Cap 1, 2-Thio-UTP, 30 nt-poly(A)) mRNA ACLY
GTTS-WK25574MR IVTScrip™ mRNA-Human ARFRP1, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ARFRP1
GTTS-WK9814MR IVTScrip™ mRNA-Human ADARB2, (Cap 0, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA ADARB2
GTTS-WK18153MR IVTScrip™ mRNA-Human Aminopeptidase-N, (Cap 1, Pseudo-UTP, 120 nt-poly(A)) mRNA Aminopeptidase-N
GTTS-WK20192MR IVTScrip™ mRNA-Human Aldehyde Dehydrogenase 1-A1, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA Aldehyde Dehydrogenase 1-A1
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
webinar

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST

REGISTER NOW